3 documents found, page 1 of 1
Motor-related health care for 5-year-old children born extremely preterm with m...
Costa, R; Aubert, AM; Seppänen, A-V; Ådén, U; Sarrechia, L; Zemlin, M; Cuttini, M; Männamaa, M; Pierrat, V; van Heijst, A; Barros, H; Johnson, SAim: To (1) determine the proportion of 5-year-old children born extremely preterm (EPT) with movement difficulties including cerebral palsy (CP) and the proportion of these children receiving motor-related health care (MRHC), and (2) describe factors associated with receiving MRHC. Method: Children born before 28 weeks’ gestation in 2011 to 2012 in 11 European countries were assessed with the Movement Assessme...
Neonatal Morbidity and Mortality in Advanced Aged Mothers-Maternal Age Is Not a...
Nourkami-Tutdibi, N; Tutdibi, E; Faas, T; Wagenpfeil, G; Draper, ES; Johnson, S; Cuttini, M; Rafei, RE; Seppänen, AV; Mazela, J; Maier, RF; Nuytten, ABackground: As childbearing is postponed in developed countries, maternal age (MA) has increased over decades with an increasing number of pregnancies between age 35–39 and beyond. The aim of the study was to determine the influence of advanced (AMA) and very advanced maternal age (vAMA) on morbidity and mortality of very preterm (VPT) infants. Methods: This was a population-based cohort study including infants...
Postnatal Corticosteroids Policy for Very Preterm Infants and Bronchopulmonary ...
Nuytten, A; Behal, H; Duhamel, A; Jarreau, PH; Torchin, H; Milligan, D; Maier, RF; Zemlin, M; Zeitlin, J; Truffert, P; EPICE Research GroupIntroduction: Postnatal corticosteroids (PNC) are effective for reducing bronchopulmonary dysplasia (BPD) in very preterm neonates but are associated with adverse effects including an increased risk of cerebral palsy. PNC use in Europe is heterogeneous across regions. This study aimed to assess whether European neonatal intensive care units (NICUs) with a low use of PNC or an explicit policy to reduce PNC use h...